Figure 6. Summary of the depressant effects of isoproterenol in combination with anesthetics. Data from 6 to 12 cells per experimental set are shown in the absence and presence of GDP beta S or PKI-(6–22)-amide. The reduction of peak INaby isoproterenol was analyzed from the steady state obtained during anesthetic exposure, as shown by the dotted lines in Figure 1and Figure 4. Error bars denote SEM;* significantly different versus steady-state of anesthetic effect;+ significantly different versus isoproterenol in combination with isoflurane plus GDP beta S;# significantly different versus isoproterenol in combination with halothane (without inhibitor).

Figure 6. Summary of the depressant effects of isoproterenol in combination with anesthetics. Data from 6 to 12 cells per experimental set are shown in the absence and presence of GDP beta S or PKI-(6–22)-amide. The reduction of peak INaby isoproterenol was analyzed from the steady state obtained during anesthetic exposure, as shown by the dotted lines in Figure 1and Figure 4. Error bars denote SEM;* significantly different versus steady-state of anesthetic effect;+ significantly different versus isoproterenol in combination with isoflurane plus GDP beta S;# significantly different versus isoproterenol in combination with halothane (without inhibitor).

Close Modal

or Create an Account

Close Modal
Close Modal